In addition, activation of Nrf2 can reduce immune surveillance against cancer cells by inhibiting the function of immune cells, so Nrf2 should be considered as a double-edged sword that is more dangerous if used incorrectly [87]. This evidence concerns the gene NFE2L2 and cancer.